News Conference News AHA 2023 Placebo-Controlled ORBITA-2 Shows PCI Eases Symptoms in Stable Angina Michael O'Riordan November 11, 2023
News Conference News AHA 2020 When PCI Decisions Ignore FFR Results, Patients Pay a Price Caitlin E. Cox November 14, 2020
News Conference News AHA 2017 Low-Dose Rivaroxaban Plus Aspirin Lowers Some Costs in COMPASS, but Full Economic Impact Unclear Todd Neale November 14, 2017
News Conference News AHA 2015 RIVER-PCI Subanalysis: No Impact of Ranolazine on Quality of Life L.A. McKeown November 09, 2015
News Conference News AHA 2012 AHA 2012: Multiple Studies Provide Clinical Guidance for Interventional Community Jason Kahn November 11, 2012